Cerebras pulls in $5.5B at IPO, then stock pops 108% on debut
AI chipmaker Cerebras raised $5.5 billion at its Nasdaq listing on Thursday. The stock priced at $56, opened at $87 and closed at $116.40 — a 108 per cent gain on the day. The debut became the first major technology IPO of 2026 and drew strong investor attention.
Cerebras, headquartered in Sunnyvale, California, designs so-called wafer-scale processors. Its flagship product, the WSE-3, is roughly 60 times the size of a standard chip and contains more than 4 trillion transistors and 900,000 AI-optimised cores. The company sells the chips to data-centre operators that train large AI models.
The first-day jump was widely read as evidence of investor appetite for AI infrastructure exposure. Cerebras's market capitalisation moved from the $19.5 billion implied by the IPO price to about $40 billion at the close. For revenue context, the company reported $720 million in revenue for its fiscal year ended February 2026.
One of the listing's biggest financial winners was Benchmark Capital, which participated in the company's 2018 Series B round. Benchmark's $25 million investment in 2018 translated into a position worth roughly $5 billion at the IPO valuation. Partner Eric Vishria has previously said he nearly turned down the original meeting.
Chief executive Andrew Feldman told Bloomberg that "the IPO gives us the balance-sheet capacity we need to support customer buying decisions." The company reiterated that it has a long-term capacity agreement with G42, the Abu Dhabi-based AI company, which accounts for around 35 per cent of revenues.
The IPO documentation also includes risk factors disclosed to the Securities and Exchange Commission. The company flagged customer concentration and competitive pressure from Nvidia's H100 and B200 product lines as material risks. Even where Cerebras chips offer specific advantages in large-model training, Nvidia retains a dominant position in the broader enterprise market.
Its customer base includes pharmaceutical research at GSK and AstraZeneca, and the University of Cambridge's Department of Applied Mathematics and Theoretical Physics. A more recent customer engagement was reported as a custom build for AI start-up Anthropic; that engagement has not been officially confirmed.
Alongside the listing, Cerebras announced three new data-centre build contracts. Two are in the United Arab Emirates, on G42 facilities, and one is in the Canadian province of Quebec. Total committed investment over three years is $2.8 billion.
The stock move attracted sector-analyst comment. Goldman Sachs's Toshiya Hari wrote in a client note that "the debut valuation captures the strongest investor enthusiasm for AI infrastructure listings in three years, though it should be read against ongoing Nvidia dominance."
Two further large technology IPOs are expected over the next month: chip-accelerator company Tenstorrent in June and AI data-labelling firm Scale AI later this month. The three filings together are being read as a sign of a recovering tech IPO market after a soft opening to the year's first quarter.